Barcelona Nut Company, Roasted and Salted Select Inshell Pistachios 21/25, flexible package, shelf life of one year. 2.75 oz., UPC 030...
⚠ Critical Alert — Stop Using Immediately
This product has been flagged with severe risks (Salmonella contamination). Stop using it now and contact the brand or FDA for a refund, repair, or replacement.
FDA Recall Notice
Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-0795-2019.
Barcelona Nut Company has initiated a recall of Roasted and Salted Select In shell Pistachios 21/25, flexible package, shelf life of one year because of salmonella contamination.
Corrective Action (per FDA)
Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-0795-2019.
Recall terminated by FDA.
✅ What you should do
- Stop using the product if you own it.
- Check the model number, lot code, or sell-by date against the recall notice above.
- Contact Barcelona Nut Company or the retailer where you bought it for a refund, replacement, or repair.
- For the most current official instructions, visit the FDA recall page.
- If you've been hurt by this product, report the incident to FDA.
Consumer Contact (per FDA)
Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-0795-2019.
Barcelona Nut Company
About the U.S. Food and Drug Administration
The FDA regulates drugs, medical devices, food, cosmetics, and tobacco. Adverse event reports and recall notices are the main public safety signal.
Visit FDA.gov →📣 Report a food, supplement, or cosmetic problem to the FDA
If you had a reaction, found contamination, or experienced a labeling problem with this product, report it to the FDA. The agency uses consumer reports to track emerging safety signals and trigger recalls.
Barcelona Nut Company Recall FAQ
Barcelona Nut Company is the subject of a food safety report: Barcelona Nut Company, Roasted and Salted Select Inshell Pistachios 21/25, flexible package, shelf life of one year. 2.75 oz., UPC 030.... The notice was published on October 25, 2018 by the U.S. Food and Drug Administration (FDA). Approximately 12,000 units are potentially affected.